𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of refractory large granular lymphocytic leukemia with 2-chlorodeoxyadenosine

✍ Scribed by Edelman, Martin J.; O'Donnell, Robert T.; Meadows, Ivan


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
125 KB
Volume
54
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


A 50-year-old man with large granular lymphocytic leukemia (CD3+, CD8+) complicated by severe pancytopenia and life-threatening infections refractory to therapy with prednisone, methotrexate, cyclosporine, and G-CSF is described. Treatment with two cycles of 2-chlorodeoxyadenosine (2-CDA) at 0.1 mg/kg by continuous intravenous infusion for 7 days each cycle resulted in resolution of cytopenias and clearance of leukemic cells. T-cell receptor gene rearrangement, initially present, was not detectable after therapy with 2-CDA. The rapid and complete response to 2-CDA after unsuccessful attempts with prior therapy suggests that 2-CDA should be considered for initial treatment of this disorder.


πŸ“œ SIMILAR VOLUMES


Development of rheumatoid arthritis afte
✍ Yoe, Joe; Gause, Barry L.; Curti, Brendan D.; Longo, Dan L.; Bagg, Adam; Kopp, W πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

The association of T-cell large granular lymphocyte (LGL) leukemia and rheumatoid arthritis is well described and it is now recognized that these patients and patients with Felty's syndrome represent different aspects of a single disease process. Most patients have rheumatoid arthritis at the time o

Decreased expression of bcl-2 (p26) in C
✍ Margarida Lima; Maria Dos Anjos Teixeira; Ana Helena Ribeiro Dos Santos; Maria L πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

The bcl-2 oncogene has been involved in the genesis of various B-cell neoplasms by means of encoding for p26, an apoptosis suppressor oncoprotein. The expression of p26 in lymphoproliferative disorders of large granular lymphocytes (LDLGL), a group of diseases whose mechanism leading to lymphocyte e